Christina Larkin

2016

In 2016, Christina Larkin earned a total compensation of $409.4K as Chief Operating Officer at Spero Therapeutics.

Compensation breakdown

Bonus$69,240
Option Awards$105,146
Salary$234,448
Other$526
Total$409,360

Larkin received $234.4K in salary, accounting for 57% of the total pay in 2016.

Larkin also received $69.2K in bonus, $105.1K in option awards and $526 in other compensation.

Rankings

In 2016, Christina Larkin's compensation ranked 11,851st out of 14,075 executives tracked by ExecPay. In other words, Larkin earned more than 15.8% of executives.

ClassificationRankingPercentile
All
11,851
out of 14,075
16th
Division
Manufacturing
4,639
out of 5,489
16th
Major group
Chemicals And Allied Products
1,660
out of 1,895
12th
Industry group
Drugs
1,346
out of 1,538
13th
Industry
Pharmaceutical Preparations
1,042
out of 1,176
11th
Source: SEC filing on April 27, 2018.

Larkin's colleagues

We found one more compensation record of an executive who worked with Christina Larkin at Spero Therapeutics in 2016.

2016

Ankit Mahadevia

Spero Therapeutics

Chief Executive Officer

News

You may also like